Market revenue in 2024 | USD 334.1 million |
Market revenue in 2030 | USD 371.4 million |
Growth rate | 1.8% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 53.67% in 2024. Horizon Databook has segmented the UK hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
HAIs, such as catheter-associated urinary tract infections (CAUTIs), central line-associated bloodstream infections (CLABSIs), and ventilator-associated pneumonia (VAP), are significant contributors to market growth.
VAP is a critical concern in UK hospitals, ventilated patients and leading to extended hospital stays, increased costs, and higher mortality rates. Researchers at the University of Warwick have developed a new model to better understand ventilator-associated pneumonia (VAP), a serious infection affecting up to 40% of ventilated patients.
This advancement is expected to drive the hospital-acquired infections diagnostics market by enhancing early detection and treatment strategies, thereby improving patient outcomes and reducing healthcare costs.
Horizon Databook provides a detailed overview of country-level data and insights on the UK hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into UK hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account